Mimedx (MDXG) Retained Earnings (2010 - 2026)

Mimedx (MDXG) has 17 years of Retained Earnings data on file, last reported at $296.3 million in Q1 2026.

• For the quarter ending Q1 2026, Retained Earnings rose 3.3% year-over-year to $296.3 million; the trailing twelve-month figure through Mar 2026 stood at $296.3 million (up 3.3% YoY), and the FY2025 full-year result was -$42.7 million, up 53.23% from the prior year.
• Retained Earnings advanced to $296.3 million in Q1 2026, from -$42.7 million in the prior quarter.
• In the past five years, Retained Earnings ranged from a high of $296.3 million in Q1 2026 to a low of -$195.7 million in Q2 2023.
• A 5-year average of $25.9 million and a median of -$57.9 million in 2025 frame the typical range for Retained Earnings.
• Across the five-year window, Retained Earnings sank 218.2% in 2022 and jumped 249.37% in 2024, its largest moves.
• Tracing MDXG's Retained Earnings over 5 years: stood at $173.8 million in 2022, then tumbled by 176.91% to -$133.7 million in 2023, then surged by 31.73% to -$91.3 million in 2024, then surged by 53.23% to -$42.7 million in 2025, then soared by 794.29% to $296.3 million in 2026.
• Business Quant data shows MDXG's Retained Earnings at $296.3 million in Q1 2026, -$42.7 million in Q4 2025, and -$57.9 million in Q3 2025.